How does Aflac make money?

AFLAC INC – Business Breakdown

The Essentials

Aflac Incorporated operates a two-segment supplemental insurance platform spanning Aflac Japan and Aflac U.S., with a product set centered on health- and life-related protection solutions. The disclosed portfolio includes cancer, medical, nursing care, whole life, accident, disability, critical illness, hospital indemnity, dental, vision, and life insurance. The company is headquartered in Columbus, Georgia, and reported approximately 12,856 employees as of December 31, 2025, with a workforce split of 44% U.S. and 55% Japan.

From a business-quality perspective, the filings portray a company whose earnings base is anchored in supplemental insurance premiums and investment income, with Japan representing the larger economic engine. The profile also indicates that the company’s financial performance is materially shaped by portfolio management, foreign exchange dynamics, and the economics of its distribution channels.

Business Model & Revenue Drivers

Aflac’s economic value creation is driven by a combination of underwriting premiums and investment income, with segment-level disclosures indicating the relative importance of each geography.

• Aflac Japan

  • Three months ended June 30, 2025:
    • Net earned premiums: $1,504 million
    • Adjusted net investment income: $207 million
    • Total adjusted revenues: $1,728 million
  • Full-year 2025 pretax earnings contribution from foreign operations, primarily Japan: $3,321 million, or 73% of total pretax earnings.

• Aflac U.S.

  • Three months ended June 30, 2025:
    • Net earned premiums: $206 million
    • Adjusted net investment income: $128 million
    • Total adjusted revenues: $336 million
  • Full-year 2025 pretax earnings contribution from the U.S.: $1,212 million, or 27% of total pretax earnings.

• Investment income as a structural earnings lever

  • The filings show that adjusted net investment income is a meaningful contributor to segment economics, particularly in Japan.
  • The company also references yen-denominated and U.S. dollar-hedged portfolios, underscoring that asset-liability management is a core part of the earnings model.

• Distribution-led premium generation

  • The business relies on distribution through agencies, banks, and brokers.
  • No complete annual revenue percentage breakdown by segment was provided in the filings.

Strategic Edge & Market Positioning

The filings do not support a claim of a durable structural moat. There is no disclosed evidence of network effects, switching costs, proprietary technology, patent protection, or cost leadership that would constitute an identifiable Economic Moat.

• Economic Moat: Not evidenced in the filings

  • No segment market share data disclosed.
  • No identified top competitors in the primary filings.
  • Products appear to be commoditized supplemental insurance, which typically limits pricing power and raises the importance of distribution efficiency and underwriting discipline.
  • The company’s reliance on agencies, banks, and brokers suggests a channel-driven model rather than a structurally protected franchise.

• Execution Advantage: Evidenced, but not structural

  • The filings imply that performance is driven by operational execution, including:
    • disciplined premium growth,
    • portfolio yield management,
    • hedging and currency management,
    • credit surveillance across commercial mortgage loans and transitional real estate loans.
  • H1 2025 U.S. new annualized premium sales increased 3.1% to $649 million, indicating some execution momentum.
  • However, this should be interpreted as operational competence rather than a defensible moat.

Outlook & Innovation Pipeline

The provided filings do not outline a formal 3-year strategic roadmap or a meaningful innovation pipeline. There is also no disclosure of patents, proprietary technologies, or R&D initiatives that would suggest a technology-led growth agenda.

• What is visible in the filings

  • Management appears focused on:
    • liability management,
    • risk-adjusted investment returns,
    • maintaining diversified yen and U.S. dollar portfolios,
    • operating within regulatory and capital constraints.
  • Performance metrics highlighted in the proxy include:
    • Japan Segment Net Earned Premium,
    • Japan Segment New Annualized Premium Sales,
    • U.S. Segment New Annualized Premium Sales,
    • Net Investment Income – Aflac Global Investments,
    • Adjusted Earnings per Diluted Share excluding FX.

• Innovation and technology

  • No patents or critical technologies were identified as drivers of future growth.
  • The filings mention investment activity in yen-denominated fixed maturity securities and tax credit investments such as solar and historic rehabilitation, but these are portfolio allocation decisions rather than innovation initiatives.

• Near-term strategic implication

  • Over the next three years, the company’s trajectory appears likely to depend more on:
    • premium growth in Japan and the U.S.,
    • investment spread management,
    • credit quality in the investment book,
    • and foreign exchange discipline, than on product innovation or technological disruption.

• Data limitation

  • A specific long-range strategic plan is not available in the provided filings.